Inspiremd

Inspiremd company information, Employees & Contact Information

Explore related pages

Related company profiles:

InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise—delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures. Our flagship product, CGuard® Prime, is the only mesh-covered carotid stent. CGuard is backed by unmatched clinical evidence and over 65,000 stents sold worldwide. We’re excited to bring the next generation of carotid stenting to physicians and patients across the United States.

Company Details

Employees
110
Founded
-
Address
6303 Waterford District Dr,
Phone
857-453-6553
Industry
Medical Device
HQ
Miami, Florida
Looking for a particular Inspiremd employee's phone or email?

Inspiremd Questions

News

InspireMD Announces Combined Financings of $58 Million - Yahoo Finance

InspireMD Announces Combined Financings of $58 Million Yahoo Finance

InspireMD Announces the Appointment of Dan Dearen to its Board of Directors - GlobeNewswire

InspireMD Announces the Appointment of Dan Dearen to its Board of Directors GlobeNewswire

40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting - Stock Titan

40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting Stock Titan

InspireMD Launches Carotid Stent System for the Preventing Strokes - Diagnostic and Interventional Cardiology

InspireMD Launches Carotid Stent System for the Preventing Strokes Diagnostic and Interventional Cardiology

InspireMD, Inc. Schedules Release of Second Quarter 2025 Financial Results and Conference Call - Quiver Quantitative

InspireMD, Inc. Schedules Release of Second Quarter 2025 Financial Results and Conference Call Quiver Quantitative

InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq

InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System Nasdaq

InspireMD to Announce Third Quarter 2025 Financial Results - The Manila Times

InspireMD to Announce Third Quarter 2025 Financial Results The Manila Times

InspireMD Reports Second Quarter 2025 Financial Results - Yahoo Finance

InspireMD Reports Second Quarter 2025 Financial Results Yahoo Finance

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - Stock Titan

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke Stock Titan

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference GlobeNewswire

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

InspireMD Announces CE Mark Approval for CGuard® Prime - GlobeNewswire

InspireMD Announces CE Mark Approval for CGuard® Prime GlobeNewswire

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal GlobeNewswire

InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation - Quiver Quantitative

InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation Quiver Quantitative

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024 - Yahoo Finance

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024 Yahoo Finance

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update Yahoo Finance

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform - Diagnostic and Interventional Cardiology

InspireMD Announces Successful First-in-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent (CAS) Platform Diagnostic and Interventional Cardiology

InspireMD announces US$58 million in combined financings and new addition to board of directors - NeuroNews International

InspireMD announces US$58 million in combined financings and new addition to board of directors NeuroNews International

InspireMD Announces Private Placement of Up to $113.6 Million - GlobeNewswire

InspireMD Announces Private Placement of Up to $113.6 Million GlobeNewswire

InspireMD Rings the Closing Bell - Nasdaq

InspireMD Rings the Closing Bell Nasdaq

InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire

FDA grants PMA for InspireMD CGuard Prime carotid stent, triggers $18M milestone payment - MassDevice

FDA grants PMA for InspireMD CGuard Prime carotid stent, triggers $18M milestone payment MassDevice

InspireMD brings in $58M, adds former Axonics CEO to board - MassDevice

InspireMD brings in $58M, adds former Axonics CEO to board MassDevice

CGuard Embolic Prevention Carotid Stent Receives French Reimbursement Approval - Diagnostic and Interventional Cardiology

CGuard Embolic Prevention Carotid Stent Receives French Reimbursement Approval Diagnostic and Interventional Cardiology

InspireMD adds former Axonics co-founder, CFO to board - MassDevice

InspireMD adds former Axonics co-founder, CFO to board MassDevice

InspireMD launches carotid stent in U.S. after FDA approval - MassDevice

InspireMD launches carotid stent in U.S. after FDA approval MassDevice

CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger - Diagnostic and Interventional Cardiology

CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger Diagnostic and Interventional Cardiology

InspireMD wins FDA IDE for carotid stent study - MassDevice

InspireMD wins FDA IDE for carotid stent study MassDevice

InspireMD brings in $17.9M to support stent trial - MassDevice

InspireMD brings in $17.9M to support stent trial MassDevice

Medical device company moves global headquarters to South Florida - The Business Journals

Medical device company moves global headquarters to South Florida The Business Journals

InspireMD's MGuard Embolic Protection Stent Shows Lower Mortality Rate in STEMI - Diagnostic and Interventional Cardiology

InspireMD's MGuard Embolic Protection Stent Shows Lower Mortality Rate in STEMI Diagnostic and Interventional Cardiology

InspireMD (NSPR) Stock Price, News & Analysis - MarketBeat

InspireMD (NSPR) Stock Price, News & Analysis MarketBeat

Five Below opens new South Florida store - The Business Journals

Five Below opens new South Florida store The Business Journals

InspireMD Launches Randomized Trial for MGuard Mesh Stent - Diagnostic and Interventional Cardiology

InspireMD Launches Randomized Trial for MGuard Mesh Stent Diagnostic and Interventional Cardiology

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard Delivery Catheters - NewMediaWire

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard Delivery Catheters NewMediaWire

Data Shows Covered Stent as Potentially Important Tool in AMI Therapy - Diagnostic and Interventional Cardiology

Data Shows Covered Stent as Potentially Important Tool in AMI Therapy Diagnostic and Interventional Cardiology

Top Inspiremd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant